BRISTOL-MYERS SQUIBB

BMY
Real-time Estimate Quote. Real-time Estimate  - 11/24 08:03:33 am
61.975USD +0.09%
Prev.61.6100
Open61.7400
High62.0100
Low61.0800
Volume9 595 949
Latest news
9m ago
1h ago
1d ago
1d ago
Chart BRISTOL-MYERS SQUIBB COMPANY
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBullishNeutral
Resistance65,465,466,7
Spread/Res.-5,4%-5,4%-7,2%
Spread/Supp.2,5%2,5%28%
Support60,460,448,4
Financials
Sales 2020 42 148 M - -
Net income 2020 1 779 M - -
Net Debt 2020 35 216 M - -
P/E ratio 2020 96,0x
Yield 2020 2,89%
Capitalization 140 B 140 B -
EV / Sales 2020 4,16x
EV / Sales 2021 3,69x
Nbr of Employees 30 000
Free-Float 77,2%
Company
Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological...

>> Read more
Sector :
Pharmaceuticals - NEC
Calendar :
2021-01-28 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 73,94 $
Last Close Price 61,92 $
Spread / Highest target 42,1%
Spread / Average Target 19,4%
Spread / Lowest Target 3,36%